In searching for a simple way to identify individuals with smoking-related lung injury, scientists at Weill Cornell Medical College have stumbled upon a potential explanation for why the class of pain-relievers known as COX-2 inhibitors increases the risk of heart problems among users.
Full article >>
Thursday, April 30, 2009
Potential lung disease biomarkers yield clues to COX-2 inhibitor side effects
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment